James Gilligan
Präsident bei TRYPTAMINE THERAPEUTICS LIMITED
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Agnes Olszewski | M | 67 | 22 Jahre | |
| James Kuo | M | 58 | 5 Jahre | |
| Peter Molloy | M | 52 | 4 Jahre | |
| Philip Jull | M | 64 | 4 Jahre | |
| Sidney Taubenfeld | M | - | 2 Jahre | |
| David S. Krause | M | - |
Tarsa Therapeutics, Inc.
 Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | 14 Jahre |
| Michael Silverman | M | - | - | |
| Christopher Ntoumenopoulos | M | - | 2 Jahre | |
| Peter Guzzo | M | - | 4 Jahre | |
| James O’Neill | M | 64 | 2 Jahre | |
| Jason Carroll | M | - | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Garner William | M | 58 | 3 Jahre | |
| Gregory M. McKee | M | 60 | 1 Jahre | |
| Dave Tousley | M | 69 | 1 Jahre | |
| Don Soland | M | 65 |
Tarsa Therapeutics, Inc.
Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | - |
| George R. Maurer | M | 68 |
Tarsa Therapeutics, Inc.
Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | 5 Jahre |
| Nicholas LaBella | M | 68 |
Tarsa Therapeutics, Inc.
Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | 3 Jahre |
| Terese Gieselman | F | 62 | 1 Jahre | |
| Thomas D'Orazio | M | - | - | |
| Luke Hayes | M | - | - | |
| Lawrence Woo | M | - | - | |
| Joy Willis | F | - | 1 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Kanada | 16 | 72,73% |
| Vereinigte Staaten | 6 | 27,27% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- James Gilligan
- Persönliches Netzwerk
